CD40 and glioblastoma: The finding that FcRn expression is upregulated in GBM and contributes to the efflux of IL-12Fc is therefore also relevant for local administration of other biologics, such as antibodies used in ICI therapy7,54, in particular for i.t. treatment with a CD40 agonistic antibody (NCT03389802) of patients with GBM.